Skip to main content
Top
Published in: Digestive Diseases and Sciences 5/2011

01-05-2011 | Original Article

Lack of Grafted Liver Rejuvenation in Adult-to-Pediatric Liver Transplantation

Authors: Susumu Eguchi, Mitsuhisa Takatsuki, Masaaki Hidaka, Akihiko Soyama, Izumi Muraoka, Tetsuo Tomonaga, Isao Shimokawa, Takashi Kanematsu

Published in: Digestive Diseases and Sciences | Issue 5/2011

Login to get access

Abstract

Background

A grafted donor liver should grow and survive under the different conditions presented by a liver transplantation recipient. It has remained unclear, however, whether the age of a grafted liver can be modulated by recipient factors.

Aims

This study investigated whether a grafted aged donor liver can be rejuvenated in a pediatric recipient.

Methods

Of 119 living donor liver transplants, ten pairs were adult-to-pediatric combinations. Senescence marker protein-30 (SMP-30), which is a protein that is remarkably reduced upon aging, was used as a senescence marker. Immunohistochemical staining for SMP-30 was performed in biopsy specimen after living donor liver transplantation (LDLT). Re-expression of SMP-30 was investigated in a biopsied adult liver (n = 6) that had been transplanted in a pediatric recipient.

Results

A remarkable expression of SMP-30 was seen in a control pediatric normal liver in comparison with that in an aged adult donor biopsy. Re-expression or an increase in SMP-30 was not observed in the liver of any pediatric recipient who had received an adult liver.

Conclusion

An adult grafted liver does not appear to rejuvenate in a pediatric recipient.
Literature
1.
go back to reference Cuende N, Miranda B, Cañón JF, Garrido G, Matesanz R. Donor characteristics associated with liver graft survival. Transplantation. 2005;79:1445–1452.PubMedCrossRef Cuende N, Miranda B, Cañón JF, Garrido G, Matesanz R. Donor characteristics associated with liver graft survival. Transplantation. 2005;79:1445–1452.PubMedCrossRef
2.
go back to reference Garcia CE, Garcia RF, Gunson B, et al. Analysis of marginal donor parameters in liver transplantation for primary biliary cirrhosis. Exp Clin Transplant. 2004;2:183–188.PubMed Garcia CE, Garcia RF, Gunson B, et al. Analysis of marginal donor parameters in liver transplantation for primary biliary cirrhosis. Exp Clin Transplant. 2004;2:183–188.PubMed
3.
go back to reference Yoshizumi T, Taketomi A, Uchiyama H, et al. Graft size, donor age, and patient status are the indicators of early graft function after living donor liver transplantation. Liver Transpl. 2008;14:1007–1013.PubMedCrossRef Yoshizumi T, Taketomi A, Uchiyama H, et al. Graft size, donor age, and patient status are the indicators of early graft function after living donor liver transplantation. Liver Transpl. 2008;14:1007–1013.PubMedCrossRef
4.
go back to reference Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. Rejuvenation of aged progenitor cells by exposure to a young systematic environment. Nature. 2005;433:760–764.PubMedCrossRef Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. Rejuvenation of aged progenitor cells by exposure to a young systematic environment. Nature. 2005;433:760–764.PubMedCrossRef
5.
go back to reference Fujita T, Uchida K, Maruyama N. Purification of senescence marker protein-30 (SMP-30) and its androgen-independent decrease with age in the rat liver. Biochim Biophys Acta. 1992;1116:122–128.PubMed Fujita T, Uchida K, Maruyama N. Purification of senescence marker protein-30 (SMP-30) and its androgen-independent decrease with age in the rat liver. Biochim Biophys Acta. 1992;1116:122–128.PubMed
6.
go back to reference Maruyama N, Ishigami A, Kondo Y. Pathophysiologic significance of senescence marker protein-30. Geriatr Gerontol Int. 2010;10(Suppl. 1):S88–S98.PubMedCrossRef Maruyama N, Ishigami A, Kondo Y. Pathophysiologic significance of senescence marker protein-30. Geriatr Gerontol Int. 2010;10(Suppl. 1):S88–S98.PubMedCrossRef
7.
go back to reference Kondo Y, Inai Y, Sato Y, et al. Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. Proc Natl Acad Sci USA. 2006;103:5723–5728.PubMedCrossRef Kondo Y, Inai Y, Sato Y, et al. Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. Proc Natl Acad Sci USA. 2006;103:5723–5728.PubMedCrossRef
8.
go back to reference Furusawa H, Sato Y, Tanaka Y, et al. Vitamin C is not essential for carnitine biosynthesis in vivo: verification in vitamin C-depleted senescence marker protein-30/gluconolactonase knockout mice. Biol Pharm Bull. 2008;31:1673–1679.PubMedCrossRef Furusawa H, Sato Y, Tanaka Y, et al. Vitamin C is not essential for carnitine biosynthesis in vivo: verification in vitamin C-depleted senescence marker protein-30/gluconolactonase knockout mice. Biol Pharm Bull. 2008;31:1673–1679.PubMedCrossRef
9.
go back to reference Maruyama N, Ishigami A, Kuramoto M, et al. Senescence marker protein-30 knockout mouse as an aging model. Ann NY Acad Sci. 2004;1019:383–387.PubMedCrossRef Maruyama N, Ishigami A, Kuramoto M, et al. Senescence marker protein-30 knockout mouse as an aging model. Ann NY Acad Sci. 2004;1019:383–387.PubMedCrossRef
10.
go back to reference Matsuyama S, Kitamura T, Enomoto N, et al. Senescence marker protein-30 regulates Akt activity and contributes to cell survival in Hep G2 cells. Biochem Biophys Res Commun. 2004;321:386–390.PubMedCrossRef Matsuyama S, Kitamura T, Enomoto N, et al. Senescence marker protein-30 regulates Akt activity and contributes to cell survival in Hep G2 cells. Biochem Biophys Res Commun. 2004;321:386–390.PubMedCrossRef
11.
go back to reference Park JK, Jeong DH, Park HY, et al. Hepatoprotective effect of arazyme on CCl4-induced acute hepatic injury in SMP30 knock-out mice. Toxicology. 2008;246:132–142.PubMedCrossRef Park JK, Jeong DH, Park HY, et al. Hepatoprotective effect of arazyme on CCl4-induced acute hepatic injury in SMP30 knock-out mice. Toxicology. 2008;246:132–142.PubMedCrossRef
12.
go back to reference Eguchi S, Takatsuki M, Hidaka M, Tajima Y, Kanematsu T. Evolution of living donor liver transplantation over 10 years: experience of a single center. Surg Today. 2008;38:795–800.PubMedCrossRef Eguchi S, Takatsuki M, Hidaka M, Tajima Y, Kanematsu T. Evolution of living donor liver transplantation over 10 years: experience of a single center. Surg Today. 2008;38:795–800.PubMedCrossRef
13.
go back to reference MacLennan WJ, Martin P, Mason BJ. Protein intake and serum albumin levels in the elderly. Gerontology. 1977;23:360–367.PubMedCrossRef MacLennan WJ, Martin P, Mason BJ. Protein intake and serum albumin levels in the elderly. Gerontology. 1977;23:360–367.PubMedCrossRef
15.
go back to reference Castleden CM, George CF. The effect of aging on the hepatic clearance of propranolol. Br J Clin Pharmacol. 1979;7:49–54.PubMed Castleden CM, George CF. The effect of aging on the hepatic clearance of propranolol. Br J Clin Pharmacol. 1979;7:49–54.PubMed
16.
go back to reference Sawada N, Ishikawa T. Reduction of potential for replicative but not unscheduled DNA synthesis in hepatocytes isolated from aged as compared to young rats. Cancer Res. 1988;48:1618–1622.PubMed Sawada N, Ishikawa T. Reduction of potential for replicative but not unscheduled DNA synthesis in hepatocytes isolated from aged as compared to young rats. Cancer Res. 1988;48:1618–1622.PubMed
17.
go back to reference Tanno M, Ogihara M, Taguchi T. Age-related changes in proliferating cell nuclear antigen levels. Mech Ageing Dev. 1996;92:53–66.PubMedCrossRef Tanno M, Ogihara M, Taguchi T. Age-related changes in proliferating cell nuclear antigen levels. Mech Ageing Dev. 1996;92:53–66.PubMedCrossRef
18.
go back to reference Bucher NL, Swaffield MN, Ditroia JF. The influence of age upon the incorporation of thymidine-1-Cl4 into the DNA of regenerating rat liver. Cancer Res. 1964;241:509–512. Bucher NL, Swaffield MN, Ditroia JF. The influence of age upon the incorporation of thymidine-1-Cl4 into the DNA of regenerating rat liver. Cancer Res. 1964;241:509–512.
19.
go back to reference Tsukamoto I, Nakata R, Kojo S. Effect of ageing on rat liver regeneration after partial hepatectomy. Biochem Mol Biol Int. 1993;30:773–778.PubMed Tsukamoto I, Nakata R, Kojo S. Effect of ageing on rat liver regeneration after partial hepatectomy. Biochem Mol Biol Int. 1993;30:773–778.PubMed
20.
go back to reference Sakai Y, Zhong R, Garcia B, Zhu L, Wall WJ. Assessment of the longevity of the liver using a rat transplant model. Hepatology. 1997;25:421–425.PubMedCrossRef Sakai Y, Zhong R, Garcia B, Zhu L, Wall WJ. Assessment of the longevity of the liver using a rat transplant model. Hepatology. 1997;25:421–425.PubMedCrossRef
21.
go back to reference Selzner M, Selzner N, Chen L, et al. Exaggerated up-regulation of tumor necrosis factor alpha-dependent apoptosis in the older mouse liver following reperfusion injury: targeting liver protective strategies to patient age. Liver Transpl. 2009;15:1594–1604.PubMedCrossRef Selzner M, Selzner N, Chen L, et al. Exaggerated up-regulation of tumor necrosis factor alpha-dependent apoptosis in the older mouse liver following reperfusion injury: targeting liver protective strategies to patient age. Liver Transpl. 2009;15:1594–1604.PubMedCrossRef
22.
go back to reference Ishigami T, Fujita T, Simbula G, et al. Regulatory effects of senescence marker protein 30 on the proliferation of hepatocytes. Ann NY Acad Sci. 2004;1019:383–387.PubMedCrossRef Ishigami T, Fujita T, Simbula G, et al. Regulatory effects of senescence marker protein 30 on the proliferation of hepatocytes. Ann NY Acad Sci. 2004;1019:383–387.PubMedCrossRef
23.
go back to reference Jeong DH, Goo MJ, Hong IH, et al. Inhibition of radiation-induced apoptosis via overexpression of SMP30 in Smad3-knockout mice liver. J Radiat Res (Tokyo). 2008;49:653–660.CrossRef Jeong DH, Goo MJ, Hong IH, et al. Inhibition of radiation-induced apoptosis via overexpression of SMP30 in Smad3-knockout mice liver. J Radiat Res (Tokyo). 2008;49:653–660.CrossRef
24.
go back to reference Handa S, Maruyama N, Ishigami A. Over-expression of senescence marker protein-30 decreases reactive oxygen species in human hepatic carcinoma Hep G2 cells. Biol Pharm Bull. 2009;32:1645–1648.PubMedCrossRef Handa S, Maruyama N, Ishigami A. Over-expression of senescence marker protein-30 decreases reactive oxygen species in human hepatic carcinoma Hep G2 cells. Biol Pharm Bull. 2009;32:1645–1648.PubMedCrossRef
25.
go back to reference Lv S, Wang JH, Liu F, et al. Senescence marker protein 30 in acute liver failure: validation of a mass spectrometry proteomics assay. BMC Gastroenterol. 2008;8:17.PubMedCrossRef Lv S, Wang JH, Liu F, et al. Senescence marker protein 30 in acute liver failure: validation of a mass spectrometry proteomics assay. BMC Gastroenterol. 2008;8:17.PubMedCrossRef
26.
go back to reference Kashio A, Amano A, Kondo Y, et al. Effect of vitamin C depletion on age-related hearing loss in SMP30/GNL knockout mice. Biochem Biophys Res Commun. 2009;390:394–398.PubMedCrossRef Kashio A, Amano A, Kondo Y, et al. Effect of vitamin C depletion on age-related hearing loss in SMP30/GNL knockout mice. Biochem Biophys Res Commun. 2009;390:394–398.PubMedCrossRef
27.
go back to reference Sato T, Seyama K, Sato Y, et al. Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am J Respir Crit Care Med. 2006;174:530–537.PubMedCrossRef Sato T, Seyama K, Sato Y, et al. Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am J Respir Crit Care Med. 2006;174:530–537.PubMedCrossRef
28.
go back to reference Koike K, Kondo Y, Sekiya M, et al. Complete lack of vitamin C intake generates pulmonary emphysema in senescence marker protein-30 knockout mice. Am J Physiol Lung Cell Mol Physiol. 2010;298:784–792.CrossRef Koike K, Kondo Y, Sekiya M, et al. Complete lack of vitamin C intake generates pulmonary emphysema in senescence marker protein-30 knockout mice. Am J Physiol Lung Cell Mol Physiol. 2010;298:784–792.CrossRef
Metadata
Title
Lack of Grafted Liver Rejuvenation in Adult-to-Pediatric Liver Transplantation
Authors
Susumu Eguchi
Mitsuhisa Takatsuki
Masaaki Hidaka
Akihiko Soyama
Izumi Muraoka
Tetsuo Tomonaga
Isao Shimokawa
Takashi Kanematsu
Publication date
01-05-2011
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 5/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1445-5

Other articles of this Issue 5/2011

Digestive Diseases and Sciences 5/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.